PTH and osteoporosis: Long after Bauer and colleagues discovered the anabolic effect of PTH in 1929 [41], recombinant parathyroid hormone (PTH)(1–34) (teriparatide, hereafter referred to as PTH) was approved as the first anabolic agent for the treatment of osteoporosis in the United States in 2002 [42].